GC Genome Corporation (KOSDAQ:340450)
South Korea · Delayed Price · Currency is KRW 8,230.00
-20.00 (-0.24%)
At close: Feb 27, 2026
GC Genome Market Cap
GC Genome has a market cap or net worth of 194.65 billion as of February 27, 2026.
Market Cap
194.65B
Enterprise Value
157.38B
Revenue
30.79B
Ranking
n/a
PE Ratio
69.68
Stock Price
8,230.00
Market Cap Chart
Since June 11, 2025, GC Genome's market cap has decreased from 262.52B to 194.65B, a decrease of -25.86%. That is a compound annual growth rate of -34.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 194.65B | 20.67% |
| Dec 30, 2025 | 161.30B | -38.56% |
| Jun 11, 2025 | 262.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 81.75T |
| Celltrion | 53.52T |
| ALTEOGEN | 21.55T |
| Sam Chun Dang Pharm. | 17.61T |
| Interojo | 215.83B |
| AptaBio Therapeutics | 211.82B |
| JW Lifescience | 211.36B |
| REYON Pharmaceutical | 208.54B |